Next 10 |
home / stock / chexf / chexf news
Avivagen ( OTCPK:CHEXF ) on Friday proposed a C$1M stock offering in private placement priced at C$0.20 per share. The company intends to use the net proceeds "to fund research and development expenses, sales and marketing costs, product registration, interest expense, working...
Avivagen press release (OTCPK:CHEXF): Q2 GAAP EPS of -C$0.02. Revenue of C$0.09M (-43.8% Y/Y). For further details see: Avivagen GAAP EPS of -C$0.02, revenue of C$0.09M
Avivagen press release (OTCQB:VIVXF): Q4 loss of C$1.55M. Revenue of C$0.27M (+3.8% Y/Y). For further details see: Avivagen loss of C$1.55M, revenue of C$0.27M
Avivagen (CHEXF): Q1 Net loss of C$1.27M.Revenue of C$0.26M (+4.0% Y/Y).Press Release For further details see: Avivagen reports FQ1 results
Avivagen ([[CHEXF]]) priced an additional debt financing of $500K through an unsecured promissory note from a Canadian Financial Institution.The note is payable on demand and bears interest at 12% pa.The proceeds will be used to support ongoing general operating activities including the ...
Avivagen ( OTCPK:CHEXF ) is accelerating its plans for commercial launch of its OxC-Beta product as a supplement for human use in response to the COVID-19 pandemic. More news on: Avivagen Inc., Healthcare stocks news, Read more ...
Avivagen ( OTCPK:CHEXF ) has completed a non-brokered private placement, issuing 2.5M units at a price of $0.50 per Unit for aggregate gross proceeds of $1.25M. More news on: Avivagen Inc., Healthcare stocks news, Read more ...
Avivagen ( OTCPK:CHEXF ) has entered into an agreement with the research subsidiary of COFCO Biotechnology Co. Ltd. More news on: Avivagen Inc., Healthcare stocks news, Read more ...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
News, Short Squeeze, Breakout and More Instantly...
Phoenix, Arizona--(Newsfile Corp. - October 2, 2019) - The Stock Day Podcast welcomed Avivagen Inc. (CHEXF) ("the Company"), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune f...
PHOENIX, May 13, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Avivagen Inc. (CHEXF) , a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, pro...
OTTAWA, March 06, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Corporation”) reported today its unaudited financial results for Q1 2019. For the three-month period ended January 31, 2019, the Corporation reported revenues of $322,125 &...